Internal Medicine, Endocrinology, Diabetes, & Metabolism · Concord, NH
NPI
1427016567
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
18 Foundry St Ste 102
Concord, NH, 03301
Phone (603) 230-5645
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,575 services
Medicare patients, 2024
504
Average age 72
Drug cost, 2024
$5.8M
8,354 prescriptions
Company payments, 2025
$1,065
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew F Kamil was code 99214 (office e&m - established), 567 times for 351 patients. In total Matthew F Kamil billed 1,575 services in 14 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 567 | 351 | $67.70 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 541 | 382 | $12.65 | $6,846 |
| 95251 Test - Miscellaneous | Office | 250 | 136 | $25.13 | $6,284 |
| 99213 Office E&M - Established | Office | 85 | 81 | $50.52 | $4,294 |
| 99204 Office E&M - New | Office | 47 | 47 | $84.77 | $3,984 |
| 99215 Office E&M - Established | Office | 29 | 22 | $104.95 | $3,043 |
| 99203 Office E&M - New | Office | 26 | 26 | $59.30 | $1,542 |
By year: 2022 $58K for 911 services; 2023 $63K for 1,037 services; 2024 $67K for 1,575 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew F Kamil prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,096 prescriptions and refills. In total Matthew F Kamil wrote 8,354 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,096 | 1,484 | 202 | $1.6M |
| Pioglitazone Hcl Generic | 632 | 1,693 | 189 | $9,419 |
| Jardiance Empagliflozin | 495 | 1,054 | 126 | $603K |
| Levothyroxine Sodium Generic | 432 | 1,258 | 117 | $4,136 |
| Rosuvastatin Calcium Generic | 298 | 861 | 105 | $4,704 |
| Atorvastatin Calcium Generic | 270 | 721 | 78 | $2,976 |
| Ozempic Semaglutide | 263 | 484 | 62 | $448K |
| Metformin Hcl Er Metformin Hcl | 225 | 575 | 67 | $2,297 |
| Tresiba Flextouch U-200 Insulin Degludec | 197 | 381 | 53 | $236K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 195 | 278 | 46 | $311K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 195 | 476 | 92 | $17K |
| Farxiga Dapagliflozin Propanediol | 186 | 425 | 49 | $234K |
| Metformin Hcl Generic | 186 | 532 | 61 | $1,348 |
| Losartan Potassium Generic | 178 | 487 | 54 | $1,166 |
| Alendronate Sodium Generic | 171 | 474 | 57 | $1,219 |
Brand drugs: 4,266 claims; generic drugs: 3,583 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew F Kamil $1,065 ($1,065 in general payments such as food, travel and fees) from 4 companies. The largest payer was Lilly USA, LLC with $840.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.